In the new format, it would've as it wouldn't have qualified under the 505b2, as Zantrene would've been dosed in combo.. So they would've had to go through the whole clinical pathway.
ill be interested to see what they will do with AML now.
Ann: Race Board and Management Team Changes, page-353
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
-0.030(1.78%) |
Mkt cap ! $282.0M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.65 | $126.2K | 76.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 120 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 500 | 1 |
View Market Depth
| Last trade - 13.57pm 03/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |